Wyeth FluShield Production Could Increase 10%-15% As Anti-Bioterror Effort

29 Oct 2001

• By The Pink Sheet

Wyeth could ramp up production of its flu vaccine FluShield by about 10%-15% as part of its initiatives to aid against bioterrorism, CEO Robert Essner told a press briefing following a meeting with HHS Secretary Tommy Thompson Oct. 26.

Wyeth FluShield Production Could Increase 10%-15% As Anti-Bioterror Effort

More from Archive

More from Pink Sheet